Serotypes, seasonal trends, and antibiotic resistance of non-typhoidal from human patients in Guangdong Province, China, 2009-2012

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Liang, Zhaoming ^a,b   Ke, Bixia ^b   Deng, Xiaoling ^b   Liang, Junhua ^b   Ran, Lu ^c   Lu, Lingling ^b   He, Dongmei ^b   Huang, Qiong ^b   Ke, Changwen ^b   Li, Zhongjie ^c   Yu, Hongjie ^c   Klena, John D ^c,d   Wu, Shuyu ^c  

^a Guangdong Provincial Institute of Biological Products and Materia Meica   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CHINA; DIARRHEA; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; SALMONELLA; SALMONELLA ALBANY; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR AGONA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR DERBY; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR INFANTIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA RISSEN; SALMONELLA STANLEY; SALMONELLA THOMPSON; SALMONELLA WELTEVREDEN; SALMONELLOSIS; SEASONAL VARIATION; SEROTYPE; SEROTYPING; VERY ELDERLY; CHILD HEALTH CARE; CLASSIFICATION; DRUG EFFECTS; HEALTH SURVEY; ISOLATION AND PURIFICATION; LABORATORY; MICROBIOLOGY; PROCEDURES; SALMONELLA INFECTIONS; SEASON;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; CHINA; DIARRHEA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LABORATORIES; MALE; POPULATION SURVEILLANCE; SALMONELLA; SALMONELLA INFECTIONS; SEASONS; SEROTYPING;

EID: 84924070229     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0784-4     Document Type: Article

References (35)

1. Galanis E, Lo Fo Wong DM, Patrick ME, Binsztein N, Cieslik A, Chalermchikit T, et al. Web-based surveillance and global Salmonella distribution, 2000-2002. Emerg Infect Dis. 2006;12(3):381-8.
2. Linam WM, Gerber MA. Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J. 2007;26(8):747-8.
3. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50(6):882-9.
4. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis. 2011;17(1):7-15.
5. Scallan E, Mahon BE, Hoekstra RM, Griffin PM. Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States. Pediatr Infect Dis J. 2013;32(3):217-21.
6. Ran L, Wu S, Gao Y, Zhang X, Feng Z, Wang Z, et al. Laboratory-based surveillance of nontyphoidal Salmonella infections in China. Foodborne Pathog Dis. 2011;8(8):921-7.
7. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489-99.
8. Sjölund-Karlsson M, Folster JP, Pecic G, Joyce K, Medalla F, Rickert R, et al. Emergence of plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother. 2009;53(5):2142-21444.
9. Sjölund-Karlsson M, Rickert R, Matar C, Pecic G, Howie RL, Joyce K, et al. Salmonella isolates with decreased susceptibility to extended-spectrum cephalosporins in the United States. Foodborne Pathog Dis. 2010;7(12):1503-9.
10. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother. 2008;52(4):1278-84.
11. Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J Antimicrob Chemother. 2007;59(5):886-92.
12. Lee HY, Su LH, Tsai MH, Kim SW, Chang HH, Jung SI, et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother. 2009;53(6):2696-9.
13. Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. Emerg Infect Dis. 2003;9(11):1455-7.
14. Koirala KD, Thanh DP, Thapa SD, Arjyal A, Karkey A, Dongol S, et al. Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever. Antimicrob Agents Chemother. 2012;56(5):2761-2.
15. Nakaya H, Yasuhara A, Yoshimura K, Oshihoi Y, Izumiya H, Watanabe H. Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC. Emerg Infect Dis. 2003;9(2):255-7.
16. Helms M, Ethelberg S, Molbak K. International Salmonella Typhimurium DT104 infections, 1992-2001. Emerg Infect Dis. 2005;11(6):859-67.
17. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis. 2004;39(4):546-51.
18. Feng Z, Li W, Varma JK. Gaps remain in China's ability to detect emerging infectious diseases despite advances since the onset of SARS and avian flu. Health Aff (Millwood). 2011;30(1):127-35.
19. Deng X, Ran L, Wu S, Ke B, He D, Yang X, et al. Laboratory-based surveillance of non-typhoidal Salmonella infections in Guangdong Province, China. Foodborne Pathog Dis. 2012;9(4):305-12.
20. Grimont PAD, Weill FX. Antigenic formulae of the Salmonella serovars. Paris, France: WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur; 2007.
21. Cockerill F. Clinical, Institute LS. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement: Clinical and Laboratory Standards Institute. 2011.
22. Varma JK, Greene KD, Ovitt J, Barrett TJ, Medalla F, Angulo FJ. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis. 2005;11(6):943-6.
23. Huang Q, Wang X, Lu L. The effectiveness of food-borne diseases training among clinicians in Guangdong, China. Food Contr. 2013;33(1):268-73.
24. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet. 2005;365(9465):1147-52.
25. Olsen SJ, Bishop R, Brenner FW, Roels TH, Bean N, Tauxe RV, et al. The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997. J Infect Dis. 2001;183(5):753-61.
26. Bassal R, Reisfeld A, Andorn N, Yishai R, Nissan I, Agmon V, et al. Recent trends in the epidemiology of non-typhoidal Salmonella in Israel, 1999-2009. Epidemiol Infect. 2012;140(8):1446-53.
27. Hendriksen RS, Bangtrakulnonth A, Pulsrikarn C, Pornruangwong S, Noppornphan G, Emborg HD, et al. Risk factors and epidemiology of the ten most common Salmonella serovars from patients in Thailand: 2002-2007. Foodborne Pathog Dis. 2009;6(8):1009-19.
28. Hopkins KL, Kirchner M, Guerra B, Granier SA, Lucarelli C, Porrero MC, et al. Multiresistant Salmonella enterica serovar 4,[5],12:i:- in Europe: a new pandemic strain? Euro Surveill. 2010;15(22):19580.
29. Switt AI, Soyer Y, Warnick LD, Wiedmann M. Emergence, distribution, and molecular and phenotypic characteristics of Salmonella enterica serotype 4,5,12:i:-. Foodborne Pathog Dis. 2009;6(4):407-15.
30. Benacer D, Thong KL, Watanabe H, Puthucheary SD. Characterization of drug resistant Salmonella enterica serotype Typhimurium by antibiograms, plasmids, integrons, resistance genes and PFGE. J Microbiol Biotechnol. 2010;20(6):1042-52.
31. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011;55(3):1148-54.
32. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32(3):331-51.
33. Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012;11:CD001167.
34. Christopher A, Mshana SE, Kidenya BR, Hokororo A, Morona D. Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania. Ital J Pediatr. 2013;39:27.
35. Cockerill F, Clinical, Institute LS. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement. In: Clinical and Laboratory Standards Institute. 2011.